BioXcel Therapeutics Inc (BTAI)
1.14
0.00 (0.00%)
USD |
NASDAQ |
Jun 21, 16:00
1.17
+0.03
(+2.63%)
After-Hours: 20:00
BioXcel Therapeutics Stock Buybacks (Quarterly): -26.74M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -26.74M |
| December 31, 2023 | -2.375M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -24.66M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.034M |
| June 30, 2021 | -101.03M |
| March 31, 2021 | |
| December 31, 2020 | 0.034M |
| September 30, 2020 | -187.01M |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00 |
| March 31, 2020 | -59.79M |
| December 31, 2019 | -0.074M |
| September 30, 2019 | -17.51M |
| June 30, 2019 | -0.23M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.001M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -56.51M |
| December 31, 2017 | -1.31M |
| September 30, 2017 | -0.751M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-187.01M
Minimum
Sep 2020
0.034M
Maximum
Dec 2020
-22.07M
Average
--
Median
Jun 2020
Stock Buybacks (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 0.00 |
| Insmed Inc | -- |
| Altimmune Inc | -0.169M |
| InfuSystems Holdings Inc | 0.365M |
| Anavex Life Sciences Corp | -7.178M |